Transmission of Quarterly Financial Statements for the Period ended March 31, 2026
Announcement attachment.
Transmission of Quarterly Financial Statements for the Period ended March 31, 2026 - 29/04/2026
Filed with PSX ·
6ix hasn’t read this filing yet.
GlaxoSmithKline Pakistan Limited on 6ix
Earlier from GlaxoSmithKline Pakistan
- Financial Results for the Quarter Ended March 31, 2026 - 27/04/2026
- Board Meeting Quarter 1- 2026 - 20/04/2026
- Board Meeting Quarter 1- 2026
- Notice of the Annual General Meeting - 09/04/2026
- Transmission of Annual Financial Statements for the year ended 31-12-2025
Later from GlaxoSmithKline Pakistan
- Certified True Copy of The Resolutions passed by the shareholders in the Annual General Meeting held on April 30, 2026 - 30/04/2026
- (Re) Appointment of Chairperson and Chief Executive Officer
- Resignation of Non-Executive Director
- Appointment of Non-Executive Director
- Appointment of Interim/ Acting Chief Financial Officer
Follow GlaxoSmithKline Pakistan into a list and get an email when it puts out news.
Follow GlaxoSmithKline Pakistan